Amazon’s Buy with Prime is a positive step, but the stock is still expensive

Amazon’s Buy with Prime is a positive step, but the stock is still expensive


Workers load packages into Amazon Rivian Electric trucks at an Amazon facility in Poway, California, November 16, 2022.

Sandy Huffaker | Reuters

Amazon‘s (AMZN) soon-to-be widely available Buy with Prime service, which allows Prime members to use their Amazon accounts to shop with other online merchants, could be a profitable revenue channel for the e-commerce giant. However, the Club holding’s stock is still expensive, a high multiple compared to the broader stock market.



Source

Kalshi says Super Bowl trading volume surpassed  billion
Business

Kalshi says Super Bowl trading volume surpassed $1 billion

Kalshi saw more than $1 billion in trading volume on Super Bowl Sunday, reaching a daily record high, according to CEO Tarek Mansour. That volume was up 2,700% year-over-year, according to the company. The platform allows users to buy event contracts for outcomes in politics, pop culture, financial markets and sports. “It was an incredible […]

Read More
Coca-Cola earnings beat estimates, as demand for its drinks begins to improve
Business

Coca-Cola earnings beat estimates, as demand for its drinks begins to improve

Cases of Coca-Cola brand soda are stacked at a Costco Wholesale store on November 13, 2025 in Simi Valley, California. Kevin Carter | Getty Images Coca-Cola reported its fourth-quarter earnings before the bell on Tuesday. Here’s what the company reported compared with what Wall Street analysts surveyed by LSEG were expecting: Adjusted earnings per share: […]

Read More
CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect
Business

CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect

A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty Images CVS Health on Tuesday reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that impressed investors, signaling steady progress in the health-care giant’s turnaround plan.  “’24 was a tough year for […]

Read More